{"id":"W2914070013","doi":"10.1177/1203475418824565","title":"Treating to Target(s) With Interleukin-17 Inhibitors","year":2019,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Western University; University of British Columbia; University of Ottawa; Memorial University of Newfoundland; Probity Medical Research; BC Children's Hospital; University Health Network; University of Toronto; Ottawa Hospital","funders":"Novartis Pharmaceuticals Canada","keywords":"Ixekizumab; Secukinumab; Medicine; Psoriatic arthritis; Psoriasis; Ankylosing spondylitis; Adverse effect; Clinical trial; Dermatology; Placebo; Interleukin 17; Safety profile; Internal medicine; Alternative medicine; Inflammation; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001141583,0.0002807538,0.000554569,0.0005397865,0.0002660991,0.0008768757,0.0003690643,0.0008484962,0.01121112],"category_scores_gemma":[0.001735362,0.0000838507,0.00106038,0.0004096213,0.0003175542,0.0006027228,0.0003880152,0.001153265,0.002256009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002976683,"about_ca_system_score_gemma":0.000943129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000316117,"about_ca_topic_score_gemma":0.0008947001,"domain_scores_codex":[0.9994585,0.0001832839,0.00009102801,0.00006118335,0.0001385275,0.00006742735],"domain_scores_gemma":[0.9990554,0.000309447,0.000339086,0.00004331964,0.0001600564,0.00009269422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002604502,0.0005909164,0.006064494,0.01004294,0.00055134,0.0008923053,0.0001637268,0.0003832999,0.0067255,0.003550845,0.06320491,0.9052252],"study_design_scores_gemma":[0.004693148,0.007826037,0.01239085,0.01428084,0.002389268,0.01350593,0.0005914993,0.001415421,0.01461474,0.006629003,0.9215919,0.000071368],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06151241,0.8029451,0.009042745,0.04578033,0.006907515,0.001242007,0.001281728,0.0003787709,0.07090937],"genre_scores_gemma":[0.3780514,0.5278375,0.01637449,0.04155993,0.01195677,0.001070948,0.001473452,0.00009598512,0.02157954],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01121112,"threshold_uncertainty_score":0.03750497,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04167188102834986,"score_gpt":0.2880805093225169,"score_spread":0.246408628294167,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}